Skip to Content

Virbac SA VIRP

Morningstar Rating
€346.00 +7.50 (2.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VIRP is trading at a 4% premium.
Price
€347.46
Fair Value
€623.57
Uncertainty
High
1-Star Price
€449.73
5-Star Price
€484.30
Economic Moat
Csbrzk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VIRP is a good fit for your portfolio.

Trading Information

Previous Close Price
€338.50
Day Range
€338.50347.50
52-Week Range
€232.50364.50
Bid/Ask
€338.00 / €352.00
Market Cap
€2.90 Bil
Volume/Avg
11,037 / 4,090

Key Statistics

Price/Earnings (Normalized)
23.39
Price/Sales
2.36
Dividend Yield (Trailing)
0.39%
Dividend Yield (Forward)
0.39%
Total Yield
0.47%

Company Profile

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Growth
Total Number of Employees
5,400

Comparables

Valuation

Metric
VIRP
VETO
TRACT
Price/Earnings (Normalized)
23.3914.18
Price/Book Value
3.182.34
Price/Sales
2.362.25
Price/Cash Flow
18.3412.46
Price/Earnings
VIRP
VETO
TRACT

Financial Strength

Metric
VIRP
VETO
TRACT
Quick Ratio
1.191.650.67
Current Ratio
2.152.681.05
Interest Coverage
28.7071.001.80
Quick Ratio
VIRP
VETO
TRACT

Profitability

Metric
VIRP
VETO
TRACT
Return on Assets (Normalized)
8.64%9.71%2.67%
Return on Equity (Normalized)
13.80%12.86%21.11%
Return on Invested Capital (Normalized)
11.84%12.34%10.99%
Return on Assets
VIRP
VETO
TRACT
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoPkpttpywZgxl$739.9 Bil
JNJ
Johnson & JohnsonLzyzwnflGly$381.2 Bil
MRK
Merck & Co IncMgszhxmdKlgcd$333.7 Bil
ABBV
AbbVie IncJycbnkhgxLxz$322.4 Bil
AZN
AstraZeneca PLC ADRYsrpyxvxdQccm$210.3 Bil
RHHBY
Roche Holding AG ADRSfxwlshtnwMrym$201.6 Bil
NVS
Novartis AG ADRBzgwmvbbtWmjx$196.0 Bil
PFE
Pfizer IncTfhllqgwMmbrt$157.1 Bil
AMGN
Amgen IncSzzwjyttpKgsp$153.4 Bil
SNY
Sanofi SA ADRCrzdbjwMtbr$124.1 Bil

Sponsor Center